Nav: Home

Cell architects: 'Smart cells' improve production of pharmaceutical raw materials

May 07, 2019

Researchers in Japan have developed an integrated synthetic biology system to construct new metabolic pathways and enzymes within microbes. By incorporating a "Design, Build, Test, Learn" (DBTL) workflow, the production of pharmaceutical raw materials could be systematically optimized. This application supports the concept of the DBTL workflow as a sustainable method for production of complex and valuable materials. The results were published on May 1 in the open access journal Nature Communications.

This study is part of a project from the New Energy and Industrial Technology Development Organization (NEDO), and was carried out by a Kobe University research team led by Assistant Professor Christopher Vavricka, Visiting Professor Michihiro Araki, Professor Tomohisa Hasunuma and Professor Akihiko Kondo. Close collaboration with a research team led by Associate Professor Hiromichi Minami (Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University) was also central to this project.

The collaborative research team is participating in a NEDO research and development project under the theme of "Development of Production Techniques for Highly Functional Biomaterials Using Smart Cells of Plants and Other Organisms (Smart Cell Project)". The goal of the Smart Cell Project is to achieve mass production of highly valued target materials by introducing genes that encode improved pathways into host microbes. This process relies heavily upon information analysis technology to re-design metabolic systems and pathways that can increase production amounts and production efficiency.

Alkaloid production was selected as a prime example for optimization because alkaloids are key intermediates in the production of pharmaceuticals including opioid pain medications. Recently, the production of alkaloid derived pain medicine has been achieved using microbes, but to make this commercially viable production yields must be improved. The key alkaloid intermediate tetrahydropapaveroline (THP) was previously produced using a combination of two enzymes: aromatic L-amino acid decarboxylase (AAAD) and monoamine oxidase (MAO). However, the relaxed specificity MAO has been a barrier to efficient THP production.

To improve this process, a metabolic design program called M-path was put to the test. This prediction software was developed by Professor Araki at Kobe University, and applied to identify novel enzymes that can bypass MAO for improved pathways to the key alkaloid intermediate THP. The M-path analysis led to the discovery of a promising natural enzyme found in silkworms called 3,4-dihydoxyphenylacetaldehyde synthase (DHPAAS) as an alternative to MAO. DHPAAS is novel in that it possesses amine oxidizing ability in additional to conventional decarboxylation activity. The team then developed structure-based enzyme engineering methods to identify key amino acids involved in determining DHPAAS enzyme activity. This enabled them to create artificial DHPAAS enzymes that can tune the ratio of decarboxylase and amine oxidase activities, leading to improved production of the key intermediate THP.

When the team introduced the newly designed metabolic pathway, including engineered enzymes, into the conventional laboratory bacterium Escherichia coli, they were able to precisely control the ratio of key intermediates dopamine (decarboxylation production) and DHPAA (oxidation product). Balancing dopamine and DHPAA levels led to improved alkaloid production within the re-designed "smart cells". To optimize the microbial production system further, over 100 metabolites were analyzed with Shimadzu mass analysis systems, enabling the team to identify bottleneck reactions and by-product forming side reactions. By incorporating the metabolite information as learning data to drive forward a new DBTL cycle, production of downstream alkaloid intermediates was further improved.

These findings demonstrate that combining advanced biotechnology and computer science is an effective strategy to rapidly develop cell factories that can produce many different kinds of valuable materials. In addition, the ability to engineer artificial enzyme functions can help to expand the range of possible production targets. Looking forward, the authors believe that the DBTL workflow will enable more efficient production of various useful materials, including pharmaceuticals, fine chemicals, biological chemicals and biofuels. This synthetic biology workflow is expected to make significant contributions to the next-generation smart cell industry for the production of complex pharmaceuticals and chemicals as well as newly discovered materials.
-end-


Kobe University

Related Microbes Articles:

Microbes seen controlling action of host's genes
Duke researchers have shown that microbes can control their animal hosts by manipulating the molecular machinery of their cells, triggering patterns of gene expression that consequently contribute to health and disease.
Three-way dance between herbivores, plants and microbes unveiled
What looks like a caterpillar chewing on a leaf or a beetle consuming fruit is likely a three-way battle that benefits most, if not all of the players involved, according to a Penn State entomologist.
Vitamin B12: Power broker to the microbes
In the microbial world, vitamin B12 is a hot commodity.
Gut microbes and bird's breath from the U at #SICB2017
University of Utah researchers will be among the scientists convening in New Orleans for the 2017 Annual Meeting for the Society for Integrative and Comparative Biology Jan.
Gut microbes contribute to recurrent 'yo-yo' obesity
New research in mice may in the future help dieters keep the weight off.
Digital microbes for munching yourself healthy
A research team at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg has taken an important step in modelling the complexity of the human gut's bacterial communities -- the microbiome -- on the computer.
How gut microbes help chemotherapy drugs
Two bacterial species that inhabit the human gut activate immune cells to boost the effectiveness of a commonly prescribed anticancer drug, researchers report Oct.
Soil microbes flourish with reduced tillage
Microbes improve soil quality by cycling nutrients and breaking plant residues down into soil organic matter.
Microbes help plants survive in severe drought
Plants can better tolerate drought and other stressors with the help of natural microbes, University of Washington research has found.
Mix and match microbes to make probiotics last
Scientists have tried to alter the human gut microbiota to improve health by introducing beneficial probiotic bacteria.

Related Microbes Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.